BioWorld | Clarivate Analytics solution affiliate program

{"description": {"enus": "BioWorld\u2019s suite of news services delivers actionable intelligence on the most innovative therapeutics and medical technologies in development. With writers and editors stationed around the globe, BioWorld reports the breaking news \u2013 and provides key perspective on hundreds of therapeutics and devices in development, the companies behind those candidates, the business development transactions that evolve the markets, and the regulatory hurdles that both challenge and guard the processes."}, "conversiontype": "sale", "reportingtimezone": "Europe/London", "cookieperiod": 7776000, "commissions": {"count": 2, "activecommissions": [{"id": "1011l632355", "type": "default", "description": "", "startdate": null, "enddate": null, "metafields": [], "status": "ACTIVE", "rates": [{"id": "1011l3999", "performancemodel": "percentagecpa", "performancevalue": 10, "scope": "campaign", "cookieperiod": null}]}, {"id": "1100l655115", "type": "promotional", "description": "Non-commissionable products", "startdate": "2021-08-03T12:03:55+00:00", "enddate": null, "metafields": [{"name": "sku", "values": ["232157", "226816"], "rules": [{"operator": "ONEOF", "value": ["232157", "226816"]}]}], "status": "ACTIVE", "rates": [{"id": "1011l3999", "performancemodel": "fixedcpa", "performancevalue": 0, "scope": "campaign", "cookieperiod": null}]}], "executiontime": "0.06327 seconds"}}

BioWorld’s suite of news services delivers actionable intelligence on the most innovative therapeutics and medical technologies in development. With writers and editors stationed around the globe, BioWorld reports the breaking news – and provides key perspective on hundreds of therapeutics and devices in development, the companies behind those candidates, the business development transactions that evolve the markets, and the regulatory hurdles that both challenge and guard the processes.

BioWorld’s suite of news services delivers actionable intelligence on the most innovative therapeutics and medical technologies in development. With writers and editors stationed around the globe, BioWorld reports the breaking news – and provides key perspective on hundreds of therapeutics and devices in development, the companies behind those candidates, the business development transactions that evolve the markets, and the regulatory hurdles that both challenge and guard the processes.